12/20/2024
4:00 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
7:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
4:15 PM | Del Giudice Matthew Paul (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | MacPherson Edward Clouston (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
12/10/2024
4:15 PM | MIRA Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
7:45 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:15 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
4:58 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
6:00 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:20 PM | MIRA Pharmaceuticals (Filer)
| Form 424B5 | |
09/27/2024
3:45 PM | MIRA Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/12/2024
3:30 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
3:01 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
3:38 PM | McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
7:20 PM | McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2024
11:15 PM | MIRA Pharmaceuticals (Filer)
| Form EFFECT | |
08/12/2024
7:37 AM | MIRA Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/08/2024
7:54 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:49 PM | MIRA Pharmaceuticals (Filer)
| Form DEF 14A | |
07/26/2024
3:55 PM | MIRA Pharmaceuticals (Filer)
| Form DEFA14A | |
07/24/2024
3:07 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
4:12 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
4:00 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:30 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:00 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
7:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
4:42 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
6:00 AM | MIRA Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
4:53 PM | Del Giudice Matthew Paul (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | MacPherson Edward Clouston (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | Jerman Michael Allen (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
6:00 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/13/2024
3:30 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:45 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2024
3:30 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad) You don’t actually want to buy Bitcoin this time around.
That’s because there’s a better way to take advantage of this new bull market…
One market expert calls it Crypto’s Hidden Gem
And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin…
That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky…
This is a much safer and better approach to ride this years’ crypto bull run.
Because believe it or not…
The 2024 crypto bull run is one you DON’T want to miss. Click Here to get the full details about Crypto’s Hidden Gem |
12/27/2023
11:15 PM | MIRA Pharmaceuticals (Filer)
| Form EFFECT | |
12/27/2023
4:27 PM | Bay Shore Trust (Filed by)
MIRA Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/27/2023
4:33 PM | Bay Shore Trust (Reporting)
McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
